Author Archive: George Goodno

George Goodno

George is the Director of State Policy Communications at BIO and enjoys the opportunity to advocate for and educate audiences about the positive societal and economic impact of the bioscience industry. Another great aspect of his job is getting to work with BIO’s broad network of state bioscience associations to help advance legislative and regulatory initiatives that will continue to improve this high-skill, high-wage industry. In his spare time, he enjoys running, skiing, hiking, gardening, and most of all, spending time with his awesome wife and two daughters.

Follow him on Twitter @ggoodno

 

Latest Posts

Governor Quinn Invites Biotech Professionals to Chicago

Gov Quinn

Governor Pat Quinn has long been a champion of the bioscience industry – both for its promise to help solve the world’s most pressing problems and as a means of elevating the economic development prospects for his state. The Governor has consistently championed educational reform, entrepreneurship, intellectual property protection, and industry regulation based on rigorous science. That is why he was named BIO’s Governor of the Year in 2011. We are furthermore honored that he Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Beantown Biotech: ‘Dominant Life Sciences Cluster’

Boston

Massachusetts’ Secretary of Housing and Economic Development, Greg Bialecki, was quoted in today’s Boston Herald as saying: “We are the dominant life sciences cluster in the world,” Greg Bialecki said, “and I don’t think that was an accident.” Thanks to the Gov. Deval Patrick administration’s support for bioscience economic development, his state has continued to grow and add biotech industry jobs as an economic engine. Boston’s  biopharm industry is comprised of more than 500 companies Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , ,

BIO’s South Dakota Affiliate Announces New Executive Director

Joni

The South Dakota Biotechnology Association has hired Joni Johnson, a renewable fuels industry expert, as the new executive director. Joni Johnson previously headed up operations for the bioethanol company Poet’s political action committee. Johnson also is a veteran of many state-wide political campaigns, and she plans to prioritize advocacy at the state and national level for the association’s membership. “They need to have a voice in critical decisions that impact this industry,” she said. “It’s Read More >

Environmental & Industrial  |  1 Comment  |  Email This Post

California Biomedical Companies Cite Lack Of Funding As Major Concern

Investment

As I have mentioned in past blog posts, the U.S. bioscience industry has demonstrated stability through turbulent economic times. While not immune from the recession, this industry generally fared much better than the overall economy and has remained a net a job generator. In April of 2012, the White House released the National Bioeconomy Blueprint noting that bioscience industries are “a large and rapidly growing segment of the world economy that provides substantial public benefit.” Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , ,

When it Comes to Patients, There is No Average

average

Next month, the National Pharmaceutical Council will host a forum — which BIO is cosponsoring — that will focus on the unique differences among treatment effects in individual patients and how policymakers, payers, and providers could shape programs and policies to acknowledge those differences. The forum, “The Myth of Average:  Why Individual Patient Differences Matter” is taking place on November 30 at the Omni Shoreham Hotel in Washington, D.C. More information and registration materials are available Read More >

Events  |  Leave a comment  |  Email This Post